Mostrando 10 resultados de: 14
Filtros aplicados
Área temáticas
Medicina y salud(9)
Farmacología y terapéutica(8)
Enfermedades(4)
Dirección general(2)
Biblioteconomía y Documentación informatica(1)
Origen
scopus(14)
Clinical drug-drug interactions: Focus on venlafaxine
ReviewAbstract: Venlafaxine (VEN) is an antidepressant agent widely used nowadays as an alternative to selective serPalabras claves:Drug-drug interactions, pharmacodynamics, pharmacokinetics, VenlafaxineAutores:Adrián LLerena, Alves G., Falcao A.C., Magalhães P.Fuentes:scopusClinical implementation of pharmacogenetics and personalized drug prescription based on e-health: The MedeA initiative
ArticleAbstract:Palabras claves:Autores:Adrián LLerena, Cobaleda J., de Andrés F., Mata-Martín C., Penãs-Lledó E.M., Pijierro A., Sánchez C.L.Fuentes:scopusAn update on HLA alleles associated with adverse drug reactions
ReviewAbstract: Adverse drug reactions (ADRs) are considered as an important cause of morbidity and mortality. The hPalabras claves:abacavir, adverse drug reactions, Allopurinol, carbamazepine, human leukocyte antigen (HLA), hypersensitivity syndrome, pharmacogenetics, Stevens-Johnson syndromeAutores:Adrián LLerena, Fricke-Galindo I., López-López M.Fuentes:scopusDrug-drug interactions. Things to do in pain management
OtherAbstract:Palabras claves:Autores:Adrián LLerena, Margargit C., Peiró A.M.Fuentes:scopusNew perspectives in personalised medicine for ethnicity in cancer: Population pharmacogenomics and pharmacometrics
ReviewAbstract:Palabras claves:Autores:Adrián LLerena, Nair S.Fuentes:scopusNews in DMPT: Leaders in Pharmacogenetics Section
OtherAbstract:Palabras claves:Autores:Adrián LLerena, Fricke-Galindo I.Fuentes:scopusInterethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: A report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)
ReviewAbstract: Mexico presents a complex population diversity integrated by Mexican indigenous (MI) (7% of Mexico'sPalabras claves:drug metabolizing enzymes, drug receptors, drug transporters, Mexicans, pharmacogeneticsAutores:Adrián LLerena, Fricke-Galindo I., Jung-Cook H., López-López M.Fuentes:scopusMetabolic phenotype pbkp_rediction from genotyping data: A bottleneck for the implementation of pharmacogenetics in drug development and clinical practice
OtherAbstract:Palabras claves:Autores:Adrián LLerena, Penãs-Lledó E.M.Fuentes:scopusPharmacogenetics in Central American healthy volunteers: Interethnic variability
ReviewAbstract: Ethnicity is one of the major factors involved in interindividual variability to drug response. ThisPalabras claves:Admixed, Afro-Caribbean, Amerindian, Biomarkers, Central America, CYP1A2, CYP2C19, CYP2D6, CYP2E1, G6PD, HLA, LDLR, MDR1, NAT2, pharmacogenetics, TP53Autores:Adrián LLerena, Barrantes R., Céspedes-Garro C., Humberto Fariñas, Naranjo M.E.G., Ramirez R., Serrano V.Fuentes:scopusPharmacogenomics in pain treatment
ReviewAbstract: The experience of chronic pain is one of the commonest reasons for seeking medical attention, beingPalabras claves:Acetaminophen, Chronic pain, clinical translation, Opioids, pharmacogenetics (PGx)Autores:Adrián LLerena, Bagdy G., Busserolles J., Eschalier A., Juhasz G., Libert F., Peiró A.M., Planelles B., Sperlagh B.Fuentes:scopus